Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Near-Patient Molecular Solutions Market Revenue Outlook: What CAGR Is Expected Through 2030?
The market for molecular solutions situated close to patients has experienced robust expansion historically and is projected to continue this upward trajectory. Forecasts indicate a rise from $4.54 billion in 2025 to $4.99 billion in 2026, reflecting a compound annual growth rate of 9.8%. Key factors driving this growth in the preceding period include the broader implementation of molecular diagnostic methodologies, an increasing need for swift test result delivery, the shift towards decentralized laboratory operations, a surge in diagnostic procedures performed in outpatient environments, and the uptake of mobile diagnostic devices.
The market for molecular solutions delivered close to the patient is poised for substantial expansion over the coming years, projecting a market size of $7.17 billion by 2030, driven by a compound annual growth rate of 9.5%. This anticipated growth throughout the forecast period is fueled by several key factors, including a heightened emphasis on personalized medicine approaches, a growing preference for at-home and remote testing options, continuous innovation in compact molecular testing technologies, the broadening scope of infectious disease monitoring, and the seamless incorporation of these solutions into broader digital health frameworks. Key developments on the horizon involve a greater acceptance of point-of-care molecular diagnostic instruments, an escalating need for swift identification of infectious diseases, the increasing use of portable PCR systems, the development of distributed diagnostic networks, and an intensified commitment to ensuring the precision of testing performed near the patient.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp
Near-Patient Molecular Solutions Market Development Factors: Which Trends Are Supporting Demand?
The burgeoning requirement for diagnostic tools used at home is anticipated to fuel the expansion of the near-patient molecular solutions market. These near-patient molecular solutions play a crucial role in empowering these home-based point-of-care devices by offering precise, swift, and easily transportable molecular diagnostic capabilities that can be dependably employed outside of conventional laboratory environments. Such devices, designed for operation by patients or untrained individuals within their residences, facilitate sample collection, analysis, or result interpretation away from traditional central laboratory facilities and in close proximity to where care is administered. The increasing consumer inclination towards health monitoring that is convenient, fast, and readily available outside of formal medical establishments is contributing to the rising demand for these home-use point-of-care systems. Illustrating this trend, a February 2023 update from the US Food & Drug Administration (FDA) indicated a significant number of Emergency Use Authorizations (EUAs) for at-home testing, encompassing one for a molecular prescription test, two for antigen prescription tests, four for over-the-counter (OTC) molecular tests, and twenty-six for OTC antigen tests, thereby underscoring the expanding market for home-based diagnostic solutions and consequently, the near-patient molecular solutions market.
Near-Patient Molecular Solutions Market Categorization By Product Type And Application
The near-patient molecular solutions market covered in this report is segmented –
1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users
Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits
Near-Patient Molecular Solutions Market Transformation Trends: Which Innovations Are Driving Change?
Key players in the near-patient molecular solutions sector are prioritizing the integration of innovative technologies, particularly isothermal nucleic acid amplification, to elevate testing speed, mobility, and the precision of diagnoses. This sophisticated molecular diagnostic method amplifies specific DNA or RNA segments at a stable temperature, bypassing the thermal cycling requirement of traditional PCR, which facilitates swift, highly sensitive, and easily transportable molecular analyses. As an illustration, June 2023 saw Cue Health Inc., a US firm devoted to molecular diagnostics, secure FDA clearance for its Cue COVID-19 Molecular Test. This test utilizes isothermal amplification and is engineered for SARS-CoV-2 RNA detection both at home and at the point of care. The device comprises a disposable cartridge, a Bluetooth-linked reader, and a mobile application that provides user instructions and delivers molecular test outcomes in approximately 20 minutes. Consequently, the Cue COVID-19 molecular test expands the availability of precise molecular diagnostics, shortens the time to results, and empowers timely health choices beyond conventional laboratory settings.
Near-Patient Molecular Solutions Market Company Landscape And Strategic Competition
Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.
Access The Complete Near-Patient Molecular Solutions Market Report:
Near-Patient Molecular Solutions Market Largest Region By Revenue And Market Share
North Americawas the largest region in the near-patient molecular solutions market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model